Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Onyx Pharmaceuticals (ONXX) Is Trading at Pre-Kyprolis Approval Levels; Is It Time to Buy?
-
Notable Analyst Rating Changes 07/23: (MDC) (ONXX) (BYD) Upgraded; (MAR) (VRSN) (WAG) Downgraded
-
Deutsche Bank Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); SEARCH Fails, But Success Wasn't Necessary
-
Notable Analyst Rating Changes 07/20: (NOK) (ONXX) (CVC) Upgraded; (CMG) (JCI) (UNP) Downgraded
-
Deutsche Bank Sees $21 of Upside in Onyx (ONXX) Shares If Kyprolis Pricing Inline with Velcade
-
Deutsche Bank Reiterates a 'Buy' on Onyx Pharmaceuticals (ONXX); Expert Weigh In on DECISION
-
Deutsche Bank Raises Price Target on Onyx Pharmaceuticals (ONXX); Adding M&A Scenario
-
Notable Analyst Rating Changes 06/21: (TJX) (EQT) (ONXX) Upgraded; (NIHD) (UA) (CNP) Downgraded
-
Deutsche Bank Starts Onyx Pharmaceuticals (ONXX) at Buy; Kyprolis Has Blockbuster Potential
-
Notable Analyst Rating Changes 06/08: (ONXX) (YHOO) (FTR) Upgraded; (NAV) (NTAP) (APD) Downgraded
-
Pre-Open Movers 9/15 (TSPT) (FNDT) (NCT) Higher; (CISG) (NFLX) (UBS) Lower (more...)
-
David Moenning's Daily State of the Markets: 7/23
